Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-5.68	67.47	71.53
Graham Fair Price	3.00	7.01	6.80
PEG	361.41	3.62	-0.78
Price/Book	3.59	1.37	1.32
Price/Cash Flow	-86.11	27.24	-196.19
Prices/Earnings	1.19	19.04	18.82
Price/Sales	10.56	2.99	2.71
Price/FCF	-86.11	27.24	-196.19
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-19.45	0.10	0.13
Operating Margin	11.63	0.06	0.05
ROA	4.70	< 0.005	< 0.005
ROE	0.02	0.02	2.37
ROIC	0.01	0.01	-13.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	< 0.005	557.63
Dividends QOQ	-0.14	-0.11	22.31
EBIT QOQ	-0.08	0.06	-22.26
EPS QOQ	-0.24	0.05	-78.07
FCF QOQ	-1.29	8.59	568.68
Revenue QOQ	-0.20	-0.05	76.42
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	76.51	73.39	-4.08
Days Sales Outstanding (DSO)	17.45	17.33	-0.68
Inventory Turnover	1.18	1.23	4.25
Debt/Capitalization	0.44	0.43	-4.39
Quick Ratio	0.12	0.49	290.90
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.81	11.00	1.79
Cash	-0.43	1.50	246.42
Capex	-0.22	-0.10	56.17
Free Cash Flow	-0.07	0.55	659.41
Revenue	5.29	5.04	-4.62
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.39	1.34	-3.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	24.35	21.12	-13.27
Naive Interpretation	Member

06 - Financial Health · Weak

Rating